Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
Crossref DOI link: https://doi.org/10.1186/s12885-016-2070-2
Published Online: 2016-01-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Feng, Zheng
Wen, Hao
Bi, Rui
Duan, Yachen
Yang, Wentao
Wu, Xiaohua